======= NKX6-2 ======= == Gene Information == * **Official Symbol**: NKX6-2 * **Official Name**: NK6 homeobox 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84504|84504]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9C056|Q9C056]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NKX6-2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NKX6-2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605955|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription factor with repressor activity involved in the regulation of axon-glial interactions at myelin paranodes in oligodendrocytes. Binds to the consensus DNA sequence 5'- (A/T)TTAATGA-3'. In oligodendrocytes, binds to MBP and PLP1 promoter regions. {ECO:0000250|UniProtKB:D3Z4R4}. |Homeobox| |regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification| |regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification| |positive regulation of cell fate commitment| |ventral spinal cord interneuron specification| |cell fate specification involved in pattern specification| |negative regulation of cell fate commitment| |spinal cord motor neuron cell fate specification| |ventral spinal cord interneuron fate commitment| |cell fate commitment involved in pattern specification| |regulation of transcription involved in cell fate commitment| |ventral spinal cord interneuron differentiation| |central nervous system myelination| |axon ensheathment in central nervous system| |spinal cord dorsal/ventral patterning| |spinal cord patterning| |negative regulation of glial cell differentiation| |regulation of cell fate commitment| |neuron fate specification| |spinal cord motor neuron differentiation| |endocrine pancreas development| |negative regulation of gliogenesis| |regulation of myelination| |oligodendrocyte development| |positive regulation of glial cell differentiation| |ventral spinal cord development| |neuromuscular process controlling balance| |cell differentiation in spinal cord| |neuron fate commitment| |regulation of glial cell differentiation| |oligodendrocyte differentiation| |positive regulation of gliogenesis| |pancreas development| |dorsal/ventral pattern formation| |cell fate specification| |myelination| |spinal cord development| |glial cell development| |neuromuscular process| |axon ensheathment| |ensheathment of neurons| |regulation of gliogenesis| |endocrine system development| |glial cell differentiation| |central nervous system neuron differentiation| |gliogenesis| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |cell fate commitment| |negative regulation of neurogenesis| |negative regulation of nervous system development| |regionalization| |negative regulation of cell development| |sequence-specific DNA binding| |pattern specification process| |positive regulation of neurogenesis| |RNA polymerase II proximal promoter sequence-specific DNA binding| |positive regulation of nervous system development| |positive regulation of cell development| |DNA-binding transcription factor activity| |negative regulation of cell differentiation| |regulation of neurogenesis| |negative regulation of transcription by RNA polymerase II| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |positive regulation of cell differentiation| |central nervous system development| |neuron differentiation| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |nervous system process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |generation of neurons| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |system process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp16|DABN 2μM R00 exp16]]|-1.98| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17700 * **Expression level (log2 read counts)**: -1.69 {{:chemogenomics:nalm6 dist.png?nolink |}}